trending Market Intelligence /marketintelligence/en/news-insights/trending/RS--Aoe44W2bhnVeTpBzGA2 content esgSubNav
In This List

Celsion to raise $15M in common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Celsion to raise $15M in common stock offering

Celsion Corp. is looking to raise up to $15 million in a common stock offering with Aspire Capital Fund LLC, a Chicago-based investment fund specializing in open market and direct equity investments in public companies.

Under the agreement, Aspire will buy up to 100,000 Celsion common shares per business day within a 24-month period.

In addition, Aspire may increase the number of common shares it will purchase for up to 2 million per business day.

Lawrenceville, N.J.-based Celsion develops and commercializes directed chemotherapy, DNA-mediated immunotherapy and RNA-based therapy products to treat cancer.